Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis

doi:10.1038/nrc2915

PMID: 20844554DOI: 10.1038/nrc2915Sep 17, 2010Paper

Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis

Nature Reviews. Cancer

Man MohanAli Shilatifard

Abstract

The RNA polymerase II (Pol II) elongation factor (ELL) was the first translocation partner of mixed lineage leukaemia (MLL) for which a biochemical function was determined. It was therefore proposed that the regulation of the elongation stage of transcription could be fundamental to MLL-based leukaemogenesis. Recent studies have identified ELL complexed with several of the translocation partners of MLL in a transcriptional super elongation complex (SEC). These studies provide evidence for the importance of the regulation of Pol II elongation in disease pathogenesis and suggest that MLL chimaeras function by licensing Pol II transcription elongation without the appropriate checkpoints.

References

A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias

Oct 1, 1992·Nature Genetics·M DjabaliG A Evans

Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias

Nov 13, 1992·Cell·D C TkachukM L Cleary

The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene

Nov 13, 1992·Cell·Y GuE Canaani

11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene

Oct 25, 1994·Proceedings of the National Academy of Sciences of the United States of America·N J Zeleznik-LeJ D Rowley

An RNA polymerase II elongation factor encoded by the human ELL gene

Mar 29, 1996·Science·A ShilatifardJ W Conaway

An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes

Jun 14, 1996·Cell·J CorralT H Rabbitts

Positional cloning of the gene for multiple endocrine neoplasia-type 1

Apr 18, 1997·Science·S C ChandrasekharappaS J Marx

ELL2, a new member of an ELL family of RNA polymerase II elongation factors

Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·A ShilatifardR C Conaway

The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX.

Jan 7, 1998·Molecular and Cellular Biology·R K SlanyM L Cleary

Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b

Jul 3, 1998·The EMBO Journal·E KroonG Sauvageau

Factors regulating the transcriptional elongation activity of RNA polymerase II

Nov 7, 1998·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A Shilatifard

The critical role of chromosome translocations in human leukemias

Feb 3, 1999·Annual Review of Genetics·J D Rowley

Identification, cloning, expression, and biochemical characterization of the testis-specific RNA polymerase II elongation factor ELL3

Jul 7, 2000·The Journal of Biological Chemistry·T MillerA Shilatifard

COMPASS: a complex of proteins associated with a trithorax-related SET domain protein

Nov 1, 2001·Proceedings of the National Academy of Sciences of the United States of America·T MillerA Shilatifard

Drosophila ELL is associated with actively elongating RNA polymerase II on transcriptionally active sites in vivo

Nov 2, 2001·The EMBO Journal·M GerberA Shilatifard

The Saccharomyces cerevisiae Set1 complex includes an Ash2 homologue and methylates histone 3 lysine 4

Dec 18, 2001·The EMBO Journal·A RoguevA F Stewart

COMPASS, a histone H3 (Lysine 4) methyltransferase required for telomeric silencing of gene expression

Jan 24, 2002·The Journal of Biological Chemistry·Nevan J KroganAli Shilatifard

The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation

Feb 14, 2002·Nucleic Acids Research·Marco BirkeRobert K Slany

Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival

Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maria E Suarez-AlmazorEduardo Bruera

Favorable impact of the t(9;11) in childhood acute myeloid leukemia

May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey E RubnitzFrederick G Behm

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party

May 3, 2002·Leukemia·J M ChessellsUNKNOWN MRC Childhood Leukaemia working party

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

Jun 12, 2002·Lancet·Ching-Hon PuiBruce Camitta

MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein

Jun 18, 2002·Journal of Biomedical Science·Mario Clemente EstableRobert G Roeder

Dot1p modulates silencing in yeast by methylation of the nucleosome core

Jun 28, 2002·Cell·Fred van LeeuwenDaniel E Gottschling

dELL is an essential RNA polymerase II elongation factor with a general role in development

Jul 4, 2002·Proceedings of the National Academy of Sciences of the United States of America·Joel C EissenbergAli Shilatifard

Disruptor of telomeric silencing-1 is a chromatin-specific histone H3 methyltransferase.

Jul 5, 2002·The Journal of Biological Chemistry·Nicolas LacosteJacques Côte

Ubiquitination of histone H2B by Rad6 is required for efficient Dot1-mediated methylation of histone H3 lysine 79.

Aug 9, 2002·The Journal of Biological Chemistry·Huck Hui NgKevin Struhl

Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties.

Oct 24, 2002·Blood·Akihiko YokoyamaMisao Ohki

Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization.

Dec 17, 2002·Molecular and Cellular Biology·James J-D HsiehStanley J Korsmeyer

Dynamic regulation of histone H3 methylated at lysine 79 within a tissue-specific chromatin domain.

Feb 27, 2003·The Journal of Biological Chemistry·Hogune ImEmery H Bresnick

MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice

Mar 7, 2003·Cancer Cell·Chi Wai SoMichael L Cleary

Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity

Apr 2, 2003·Molecular Cell·Huck Hui NgKevin Struhl

The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation

Apr 2, 2003·Molecular Cell·Nevan J KroganAli Shilatifard

The RNA polymerase II elongation complex

Apr 5, 2003·Annual Review of Biochemistry·Ali ShilatifardJoan Weliky Conaway

AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases.

Jun 14, 2003·Blood·Claudia SchochTorsten Haferlach

Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials

Jul 9, 2003·British Journal of Haematology·Sverre O LieGöran Gustafsson

Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods

Aug 20, 2003·Cancer·Angelique W LeviBrigitte M Ronnett

Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias

Sep 6, 2003·Cancer Cell·Chi Wai SoMichael L Cleary

c-Met expression in tall cell variant papillary carcinoma of the thyroid

Sep 26, 2003·Cancer·Heather C NardoneBarry L Ziober

Dimerization of MLL fusion proteins immortalizes hematopoietic cells

Oct 3, 2003·Cancer Cell·Mary Ellen MartinJay L Hess

Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus

Mar 3, 2004·Molecular Cell·Christina M HughesMatthew Meyerson

The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote

Jun 4, 2004·Genes & Development·Dirk SchübelerMark Groudine

Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression

Jun 17, 2004·Molecular and Cellular Biology·Akihiko YokoyamaMichael L Cleary

The significance of the Wnt pathway in the pathology of human cancers

Jun 19, 2004·Pathology·Rooshdiya KarimSoon Lee

Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukaemia: report from a referral centre in Israel

Jul 20, 2004·British Journal of Haematology·Batia StarkIsaac Yaniv

Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins

Dec 1, 2004·Annual Review of Genetics·Leonie Ringrose, Renato Paro

Wnt signalling in stem cells and cancer

Apr 15, 2005·Nature·Tannishtha Reya, Hans Clevers

Wnt signaling in the intestinal epithelium: from endoderm to cancer

Apr 19, 2005·Genes & Development·Alex Gregorieff, Hans Clevers

hDOT1L links histone methylation to leukemogenesis

Apr 27, 2005·Cell·Yuki OkadaYi Zhang

Molecular regulation of histone H3 trimethylation by COMPASS and the regulation of gene expression

Sep 20, 2005·Molecular Cell·Jessica SchneiderAli Shilatifard

❮ Previous

Next ❯

Citations

Bromodomains as therapeutic targets.

Sep 22, 2011·Expert Reviews in Molecular Medicine·Susanne MullerStefan Knapp

Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential.

Aug 13, 2011·Cell Death and Differentiation·J M HeddlestonJ N Rich

In focus: MLL-rearranged leukemia

Mar 22, 2013·Leukemia·J de BoerO Williams

Trithorax group proteins: switching genes on and keeping them active.

Nov 24, 2011·Nature Reviews. Molecular Cell Biology·Bernd SchuettengruberGiacomo Cavalli

The super elongation complex (SEC) family in transcriptional control.

Aug 17, 2012·Nature Reviews. Molecular Cell Biology·Zhuojuan LuoAli Shilatifard

Targeting epigenetic readers in cancer.

Aug 17, 2012·The New England Journal of Medicine·Mark A DawsonBrian J P Huntly

ELL, a novel TFIIH partner, is involved in transcription restart after DNA repair

Oct 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sophie MourguesGiuseppina Giglia-Mari

WRAD: enabler of the SET1-family of H3K4 methyltransferases.

Jun 2, 2012·Briefings in Functional Genomics·Patricia Ernst, Christopher R Vakoc

The super elongation complex (SEC) and MLL in development and disease.

Apr 5, 2011·Genes & Development·Edwin SmithAli Shilatifard

Dynamic transcriptional events in embryonic stem cells mediated by the super elongation complex (SEC)

Jul 19, 2011·Genes & Development·Chengqi LinAli Shilatifard

Transcriptional elongation checkpoint control in development and disease

May 24, 2013·Genes & Development·Edwin Smith, Ali Shilatifard

The super elongation complex family of RNA polymerase II elongation factors: gene target specificity and transcriptional output.

May 2, 2012·Molecular and Cellular Biology·Zhuojuan LuoAli Shilatifard

Drosophila SETs its sights on cancer: Trr/MLL3/4 COMPASS-like complexes in development and disease

Mar 6, 2013·Molecular and Cellular Biology·Marc Alard Morgan, Ali Shilatifard

The conserved PHD1-PHD2 domain of ZFP-1/AF10 is a discrete functional module essential for viability in Caenorhabditis elegans

Dec 25, 2012·Molecular and Cellular Biology·Daphne C AvgoustiAlla Grishok

The COMPASS family of H3K4 methylases in Drosophila.

Aug 31, 2011·Molecular and Cellular Biology·Man MohanAli Shilatifard

HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma

Aug 13, 2013·The Journal of Clinical Investigation·Shugaku TakedaJames J Hsieh

Targeting epigenetic programs in MLL-rearranged leukemias

Dec 14, 2011·Hematology·Kathrin M Bernt, Scott A Armstrong

Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.

Jan 3, 2012·Blood·Huining KangCheryl L Willman

Regulation of MYC expression and differential JQ1 sensitivity in cancer cells

Jan 28, 2014·PloS One·Trent FowlerAnanda L Roy

DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy

May 27, 2014·PloS One·Wei LiuMichele Redell

MLL-SEPTIN gene fusions in hematological malignancies

Jul 1, 2011·Biological Chemistry·Nuno CerveiraManuel R Teixeira

Conference Scene: epigenetics eh! The first formal meeting of the Canadian epigenetics community

Dec 1, 2011·Epigenomics·Alan Underhill, Michael J Hendzel

Promises and challenges of anticancer drugs that target the epigenome

Dec 1, 2011·Epigenomics·Inge VerbruggeMichael Bots

Trithorax and polycomb cooperation in MLL fusion acute leukemia

Jun 5, 2013·Haematologica·Helene Méreau, Juerg Schwaller

TET1 plays an essential oncogenic role in MLL-rearranged leukemia

Jul 3, 2013·Proceedings of the National Academy of Sciences of the United States of America·Hao HuangJianjun Chen

C/EBPα: critical at the origin of leukemic transformation

Jan 8, 2014·The Journal of Experimental Medicine·Jae-Seok Roe, Christopher R Vakoc

The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis.

Jun 6, 2012·Annual Review of Biochemistry·Ali Shilatifard

RNA polymerase II elongation control.

Mar 13, 2012·Annual Review of Biochemistry·Qiang ZhouDavid H Price

Chromatin dynamics: H3K4 methylation and H3 variant replacement during development and in cancer

Mar 29, 2014·Cellular and Molecular Life Sciences : CMLS·Moonmoon DebSamir Kumar Patra

The pathogenesis of mixed-lineage leukemia.

Oct 25, 2011·Annual Review of Pathology·Andrew G Muntean, Jay L Hess

Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis

Oct 1, 2014·Cell Research·Yiyu DongJames J Hsieh

A role for WDR5 in TRA-1/Gli mediated transcriptional control of the sperm/oocyte switch in C. elegans

Apr 1, 2014·Nucleic Acids Research·Tengguo Li, William G Kelly

New insights in AML biology from genomic analysis

Oct 15, 2014·Seminars in Hematology·Ashley M Perry, Eyal C Attar

A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin II-induced cardiac hypertrophy

Feb 26, 2015·Journal of Molecular and Cellular Cardiology·Xinyu WengYong Xu

The leukemogenic fusion gene MLL-AF9 alters microRNA expression pattern and inhibits monoblastic differentiation via miR-511 repression

Jan 15, 2016·Journal of Experimental & Clinical Cancer Research : CR·Katrin K FleischmannIrene Schmid

Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?

Mar 23, 2011·Seminars in Oncology·Olatoyosi OdenikeWendy Stock

Histone lysine methylation and demethylation pathways in cancer

Oct 19, 2010·Biochimica Et Biophysica Acta·Radhika A Varier, H T Marc Timmers

Drugging Chromatin in Cancer: Recent Advances and Novel Approaches

Nov 23, 2015·Molecular Cell·Sheng F CaiScott A Armstrong

Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t(4;11)(q21;q23)

Dec 7, 2013·Genes, Chromosomes & Cancer·Syed Khizer HasanFrancesco Lo-Coco

RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes

Feb 13, 2014·Molecular Cancer·Katrin K FleischmannAdelbert A Roscher

The epigenetic factor Kmt2a/Mll1 regulates neural progenitor proliferation and neuronal and glial differentiation

Oct 7, 2014·Developmental Neurobiology·Yin-Cheng HuangYi-Chuan Cheng

Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond

Jun 30, 2015·Experimental Hematology·Chun-Wei Chen, Scott A Armstrong

ZF-CxxC domain-containing proteins, CpG islands and the chromatin connection

May 24, 2013·Biochemical Society Transactions·Hannah K LongRobert J Klose

Substituted purine and 7-deazapurine compounds as modulators of epigenetic enzymes: a patent evaluation (WO2012075381)

Mar 2, 2013·Expert Opinion on Therapeutic Patents·Daniel B LipkaClarissa Gerhauser

Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene

May 24, 2014·Neuron·Atsushi TakataMaria Karayiorgou

A lesson learned from the H3.3K27M mutation found in pediatric glioma: a new approach to the study of the function of histone modifications in vivo?

Aug 3, 2013·Cell Cycle·Kui Ming ChanZhiguo Zhang

An open and shut case for the role of NSD proteins as oncogenes.

Sep 17, 2011·Transcription·Agda Karina Lucio-Eterovic, Phillip B Carpenter

Enforcing the pause: transcription factor Sp3 limits productive elongation by RNA polymerase II

May 17, 2013·Cell Cycle·Alvaro Valin, Grace Gill

Substrate and product specificities of SET domain methyltransferases.

Aug 19, 2011·Epigenetics : Official Journal of the DNA Methylation Society·Paul A Del Rizzo, Raymond C Trievel

Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4

Apr 17, 2014·Cancer Cell·Han LiuJames J Hsieh

❮ Previous

Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.